Logo image
Recent advances and impending challenges for the radiopharmaceutical sciences in oncology
Journal article   Peer reviewed

Recent advances and impending challenges for the radiopharmaceutical sciences in oncology

Suzanne E Lapi, Peter J H Scott, Andrew M Scott, Albert D Windhorst, Brian M Zeglis, May Abdel-Wahab, Richard P Baum, John M Buatti, Francesco Giammarile, Ana P Kiess, …
The lancet oncology, Vol.25(6), pp.e236-e249
06/2024
DOI: 10.1016/S1470-2045(24)00030-5
PMCID: PMC11340123
PMID: 38821098
url
https://pmc.ncbi.nlm.nih.gov/articles/PMC11340123/pdf/nihms-2015147.pdfView
Open Access

Abstract

This paper is the first of a Series on theranostics that summarises the current landscape of the radiopharmaceutical sciences as they pertain to oncology. In this Series paper, we describe exciting developments in radiochemistry and the production of radionuclides, the development and translation of theranostics, and the application of artificial intelligence to our field. These developments are catalysing growth in the use of radiopharmaceuticals to the benefit of patients worldwide. We also highlight some of the key issues to be addressed in the coming years to realise the full potential of radiopharmaceuticals to treat cancer.

Details

Metrics

Logo image